These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18199567)

  • 1. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.
    Wassink AM; van der Graaf Y; Olijhoek JK; Visseren FL;
    Eur Heart J; 2008 Jan; 29(2):213-23. PubMed ID: 18199567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.
    Arnlöv J; Ingelsson E; Sundström J; Lind L
    Circulation; 2010 Jan; 121(2):230-6. PubMed ID: 20038741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
    Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP;
    Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome.
    Benetos A; Thomas F; Pannier B; Bean K; Jégo B; Guize L
    Am J Cardiol; 2008 Jul; 102(2):188-91. PubMed ID: 18602519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
    J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.
    Selcuk H; Temizhan A; Selcuk MT; Sen T; Maden O; Tekeli S; Sasmaz A
    Coron Artery Dis; 2009 Sep; 20(6):370-5. PubMed ID: 19609207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and all-cause mortality in older men and women.
    Forti P; Pirazzoli GL; Maltoni B; Bianchi G; Magalotti D; Muscari A; Mariani E; Ravaglia G; Zoli M
    Eur J Clin Invest; 2012 Sep; 42(9):1000-9. PubMed ID: 22591032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
    Polis AB; Abate N; Catapano AL; Ballantyne CM; Davidson MH; Smugar SS; Tershakovec AM
    Metab Syndr Relat Disord; 2009 Dec; 7(6):601-10. PubMed ID: 19929597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
    Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
    Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome.
    Hjortnaes J; Algra A; Olijhoek J; Huisman M; Jacobs J; van der Graaf Y; Visseren F
    J Rheumatol; 2007 Sep; 34(9):1882-7. PubMed ID: 17696269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population.
    Andreadis EA; Tsourous GI; Tzavara CK; Georgiopoulos DX; Katsanou PM; Marakomichelakis GE; Diamantopoulos EJ
    Am J Hypertens; 2007 May; 20(5):558-64. PubMed ID: 17485022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between ankle-brachial index and cardiovascular or all-cause mortality in metabolic syndrome of elderly Chinese.
    Xu Y; Li J; Luo Y; Wu Y; Zheng L; Yu J; Ma J; Gu J; Hu D
    Hypertens Res; 2007 Jul; 30(7):613-9. PubMed ID: 17785929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions.
    Guize L; Thomas F; Pannier B; Bean K; Jego B; Benetos A
    Diabetes Care; 2007 Sep; 30(9):2381-7. PubMed ID: 17563336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.